{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:34:26Z","timestamp":1786995266468,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020473","name":"Australasian Paediatric Endocrine Group Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009119","name":"Children's Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009119","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omtm.2024.101232","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T12:44:02Z","timestamp":1710247442000},"page":"101232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["AAV-delivered hepato-adrenal cooperativity in steroidogenesis: Implications for gene therapy for congenital adrenal hyperplasia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8476-220X","authenticated-orcid":false,"given":"Lara E.","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva B.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Koyyalamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Wotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Ginn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian E.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101232_bib1","first-page":"249","article-title":"The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia","volume":"86","author":"Wilkins","year":"1950","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"10.1016\/j.omtm.2024.101232_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-11-1-1","article-title":"Treatment of congenital adrenal hyperplasia with cortisone","volume":"11","author":"Wilkins","year":"1951","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI102438","article-title":"The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern","volume":"30","author":"Bartter","year":"1951","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101232_bib4","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2024.101232_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ijns6030063","article-title":"Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme","volume":"6","author":"Lai","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.omtm.2024.101232_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000526401","article-title":"Ethnic and National Differences in Congenital Adrenal Hyperplasia Incidence: A Systematic Review and Meta-Analysis","volume":"96","author":"Navarro-Zambrana","year":"2023","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.omtm.2024.101232_bib7","article-title":"Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study","volume":"28","author":"Berglund","year":"2023","journal-title":"Lancet Reg. Health. Eur."},{"key":"10.1016\/j.omtm.2024.101232_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.omtm.2024.101232_bib9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/clinem\/dgac751","article-title":"Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies","volume":"108","author":"Graves","year":"2023","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib10","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/jc.2016-1916","article-title":"A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia","volume":"101","author":"Nella","year":"2016","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/cen.13813","article-title":"Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia","volume":"89","author":"Mallappa","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.omtm.2024.101232_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib13","first-page":"1797","article-title":"Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia","volume":"102","author":"Jones","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.12688\/f1000research.17778.1","article-title":"Emerging medical therapies for congenital adrenal hyperplasia","volume":"8","author":"Speiser","year":"2019","journal-title":"F1000Res."},{"key":"10.1016\/j.omtm.2024.101232_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/hum.2022.161","article-title":"Onasemnogene Abeparvovec in Type 1 Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis","volume":"34","author":"Pascual-Morena","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnins.2016.00238","article-title":"Functional Zonation of the Adult Mammalian Adrenal Cortex","volume":"10","author":"Vinson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2024.101232_bib17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/endo-123-4-1923","article-title":"Steroid 21-hydroxylase deficiency in mice","volume":"123","author":"Gotoh","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtm.2024.101232_bib18","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.gt.3301018","article-title":"Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice","volume":"6","author":"Tajima","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/gt.2017.10","article-title":"An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21(-\/-) mouse model","volume":"24","author":"Perdomini","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/hum.2017.203","article-title":"Biology of the Adrenal Gland Cortex Obviates Effective Use of Adeno-Associated Virus Vectors to Treat Hereditary Adrenal Disorders","volume":"29","author":"Markmann","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR gene editing is negated by pre-existing immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib24","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/mt.2009.139","article-title":"Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation","volume":"17","author":"Dane","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib25","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1152\/ajpendo.00705.2006","article-title":"Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment","volume":"293","author":"Bielohuby","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.71.1.29","article-title":"A Crystalline Pressor Substance (Angiotonin) Resulting from the Reaction between Renin and Renin-Activator","volume":"71","author":"Page","year":"1940","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2024.101232_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1113\/jphysiol.1940.sp003850","article-title":"The substance causing renal hypertension","volume":"98","author":"Braun-Menendez","year":"1940","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.omtm.2024.101232_bib28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbrc.2003.11.177","article-title":"Guideline to reference gene selection for quantitative real-time PCR","volume":"313","author":"Radoni\u0107","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2024.101232_bib29","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/cvr\/cvac160","article-title":"High salt intake activates the hypothalamic-pituitary-adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice","volume":"119","author":"Costello","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtm.2024.101232_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf6710","article-title":"Fatty acid desaturase 2 determines the lipidomic landscape and steroidogenic function of the adrenal gland","volume":"9","author":"Witt","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2024.101232_bib31","doi-asserted-by":"crossref","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib32","first-page":"484","article-title":"The pituitary gland in untreated Addison's disease. A histologic and immunocytologic study of 18 adenohypophyses","volume":"107","author":"Scheithauer","year":"1983","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.omtm.2024.101232_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/jcem-57-2-294","article-title":"Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol","volume":"57","author":"DeBold","year":"1983","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2024.101232_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/endo-22-4-458","article-title":"Autotransplantation and Regeneration of the Adrenal Gland","volume":"22","author":"Ingle","year":"1938","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtm.2024.101232_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ar.1090720210","article-title":"A study of corticoadrenal cells","volume":"72","author":"Zwemer","year":"1938","journal-title":"Anat. Rec."},{"key":"10.1016\/j.omtm.2024.101232_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081865","article-title":"Cell proliferation, movement and differentiation during maintenance of the adult mouse adrenal cortex","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101232_bib37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.devcel.2013.07.016","article-title":"Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells","volume":"26","author":"Freedman","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtm.2024.101232_bib38","first-page":"107","article-title":"A study of adrenal cortex morphology","volume":"12","author":"Zwemer","year":"1936","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2024.101232_bib39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2024.101232_bib40","author":"Barrett"},{"key":"10.1016\/j.omtm.2024.101232_bib41","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101232_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/gt.2008.64","article-title":"Potential of AAV vectors in the treatment of metabolic disease","volume":"15","author":"Alexander","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mt.2009.88","article-title":"AAV2\/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice","volume":"17","author":"Cunningham","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib44","article-title":"Efficient in\u00a0vivo editing of OTC-deficient patient-derived primary human hepatocytes","volume":"2","author":"Ginn","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.omtm.2024.101232_bib45","author":"Adrenas"},{"key":"10.1016\/j.omtm.2024.101232_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","article-title":"Etranacogene Dezaparvovec: First Approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtm.2024.101232_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MED.0000000000000723","article-title":"Emerging treatment for congenital adrenal hyperplasia","volume":"29","author":"White","year":"2022","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.omtm.2024.101232_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1507\/endocrj.EJ16-0112","article-title":"Extra-adrenal induction of Cyp21a1 ameliorates systemic steroid metabolism in a mouse model of congenital adrenal hyperplasia","volume":"63","author":"Naiki","year":"2016","journal-title":"Endocr. J."},{"key":"10.1016\/j.omtm.2024.101232_bib49","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/hum.2022.005","article-title":"AAV-mediated gene therapy for patients' fibroblasts, iPS cells, and a mouse model of congenital adrenal hyperplasia","volume":"33","author":"Naiki","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30880-w","article-title":"Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice","volume":"13","author":"Pontoizeau","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101232_bib51","first-page":"A93","article-title":"Durable CYP21A2 gene therapy in non-human primates for treatment of congenital adrenal hyperplasia. ESGCT 27th Annual Congress In collaboration with SETGyc Barcelona, Spain October 22-25, 2019 Abstracts","author":"Eclov","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101232_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.stem.2019.04.012","article-title":"The Adult Adrenal Cortex Undergoes Rapid Tissue Renewal in a Sex-Specific Manner","volume":"25","author":"Grabek","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2024.101232_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.omtm.2021.11.011","article-title":"Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8","volume":"24","author":"Cabanes-Creus","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101232_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101232_bib55","article-title":"Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings","volume":"8","author":"Au","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.omtm.2024.101232_bib56","doi-asserted-by":"crossref","first-page":"A82","DOI":"10.1210\/jendso\/bvab048.165","volume":"5","author":"Merke","year":"2021","journal-title":"J.\u00a0Endocr. Soc."},{"key":"10.1016\/j.omtm.2024.101232_bib57","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1073\/pnas.84.9.2819","article-title":"Lethal deletion of the complement component C4 and steroid 21-hydroxylase genes in the mouse H-2 class III region, caused by meiotic recombination","volume":"84","author":"Shiroishi","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T07:04:31Z","timestamp":1726383871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2329050124000482"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101232","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-delivered hepato-adrenal cooperativity in steroidogenesis: Implications for gene therapy for congenital adrenal hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101232"}}